Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Itraconazole on the Pharmacokinetics of BI 1815368 in Healthy Male Subjects
NCT05965583Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2023
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of BI 1815368, sponsored by Boehringer Ingelheim. Primary endpoints: Area Under the Concentration-time Curve Over the Time Interval From 0 Extrapolated to Infinity up to 143 hours and Maximum Measured Concentration in Plasma up to 143 hours. Started Aug 2023; status: completed.
02
Drugs
BI 1815368
Beyond the preview
Go deeper on NCT05965583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05965583.